Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00090831 · ClinicalTrials.gov registry record

Investigating the Role of Serotonin in Emotional Processing Through the Use of Tryptophan Depletion

A clinical trial, sponsored by National Institute of Mental Health (NIMH).

Completed
Registry status
91
Enrollment target

NCT00090831 is a clinical trial that has completed, run by National Institute of Mental Health (NIMH). The registered enrollment target is 91 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00090831 has completed, sponsored by National Institute of Mental Health (NIMH).

COMPLETED
Registry status
91 participants
Enrollment target

Study Summary

This study will examine the role of serotonin function in the brain. Serotonin, one of the brain's natural chemicals, connects with receptors on brain cells to regulate emotion, anxiety, sleep, stress hormones, and other body functions that are disturbed in various mood and anxiety disorders. Also, the research will look at the function of particular brain areas, how they are involved in regulating emotions, and how serotonin is involved in the regulation of their function. The procedures entailed are tryptophan depletion and magnetic resonance imagining (MRI). Also, researchers' understanding of the genetic causes of mood and anxiety disorders will increase through examination of participants' DNA. Adults in good health, ages 20 through 50, may be eligible for this study. Among those not eligible are females who are pregnant or breast feeding, patients with psychiatric or central nervous system disease, and those taking medications that would interfere with study results. At the first visit, patients will be asked about their general mood, degree of nervousness, thinking skills, and behavior. The session will last from 1.5 to 2.0 hours. A blood sample of about 2 tablespoons will be drawn, for DNA study. Participants will undergo the following procedures and tests: * Physical examination. * Test of vital signs, lying and standing. * Electrocardiogram. * Collection of blood for chemistry and hematology. * Urinalysis. * HIV, urine drug, and hepatitis screening. * Psychiatric screening. * (SqrRoot) -HCG pregnancy test, if applicable. At the second visit, patients will receive either tryptophan depletion or placebo, and 5 hours later, the study will begin, to last up to 2 additional hours. Patients will be asked periodically about their emotional state or changes in their well-being. The MRI system will create images of the brain's blood flow and measure glucose metabolism as a measure of brain activity. During the MRI scan, patients will hear knocking or beeping s

Trial Details

FieldValue
Enrollment Target 91 participants
Start Date 2004-08-31
Est. Completion 2012-09-17

What the Registry Record Tells You About NCT00090831

The ClinicalTrials.gov registry entry for NCT00090831 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 91 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is National Institute of Mental Health (NIMH), which has 343 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 0 interventions.

NCT00090831 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT00090831 about?

NCT00090831 is a clinical study titled "Investigating the Role of Serotonin in Emotional Processing Through the Use of Tryptophan Depletion". This study will examine the role of serotonin function in the brain. Serotonin, one of the brain's natural chemicals, connects with receptors on brain cells to regulate emotion, anxiety, sleep, stress hormones, and other body functions that are disturbed in various mood and anxiety disorders. Also, ...

What is the current status of trial NCT00090831?

This trial is currently completed. The enrollment target is 91 participants. The study started on 2004-08-31. Estimated completion is 2012-09-17.

Who is sponsoring clinical trial NCT00090831?

This trial is sponsored by National Institute of Mental Health (NIMH), which has 343 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.